Jan Basile to Risk Factors
This is a "connection" page, showing publications Jan Basile has written about Risk Factors.
Connection Strength
0.796
-
A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever. Hosp Pract (1995). 2016; 44(1):9-20.
Score: 0.067
-
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). J Diabetes Complications. 2013 May-Jun; 27(3):280-6.
Score: 0.054
-
Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):661-3.
Score: 0.046
-
Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk. J Clin Hypertens (Greenwich). 2010 Aug; 12(8):627-30.
Score: 0.046
-
Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):472-7.
Score: 0.046
-
Identifying and managing factors that interfere with or worsen blood pressure control. Postgrad Med. 2010 Mar; 122(2):35-48.
Score: 0.045
-
Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):743-5.
Score: 0.044
-
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J. 2009 Oct; 102(10 Suppl):S1-S12.
Score: 0.043
-
Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2009 Apr; 11(4):238-40.
Score: 0.042
-
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract. 2009 Apr; 63(4):656-66.
Score: 0.041
-
Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease. South Med J. 2007 Dec; 100(12):1200-7.
Score: 0.038
-
Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention. South Med J. 2007 May; 100(5):499-505.
Score: 0.037
-
Management of global risk across the continuum of hypertensive heart disease. J Clin Hypertens (Greenwich). 2006 Aug; 8(8 Suppl 2):21-30; quiz 39-40.
Score: 0.035
-
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction. J Cardiometab Syndr. 2006; 1(5):358-61.
Score: 0.033
-
Hypertension curriculum review. The importance of systolic blood pressure elevation in elderly persons. J Clin Hypertens (Greenwich). 2004 Aug; 6(8):461-5.
Score: 0.030
-
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
Score: 0.029
-
Beta-blockers for preventing sudden cardiac death. Postgrad Med. 2003 Dec; 114(6 Suppl Role):30-4.
Score: 0.029
-
Systolic blood pressure elevation: it's where the action is. Drugs Aging. 2003; 20(4):287-8.
Score: 0.027
-
American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002 Apr; 15(4 Pt 1):372-9.
Score: 0.026
-
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016 Apr; 18(4):299-307.
Score: 0.017
-
Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51.
Score: 0.008
-
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25.
Score: 0.007
-
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8.
Score: 0.006